BlackRock Fund Advisors - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 24 filers reported holding RECRO PHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q4 2016$151,000
-7.9%
18,677
+1.0%
0.00%
Q3 2016$164,000
+35.5%
18,499
+21.2%
0.00%
Q2 2016$121,000
+83.3%
15,268
+37.5%
0.00%
Q1 2016$66,000
-38.9%
11,105
-7.2%
0.00%
Q4 2015$108,000
-22.3%
11,971
+4.0%
0.00%
Q3 2015$139,000
+85.3%
11,515
+97.9%
0.00%
Q2 2015$75,0005,8200.00%
Other shareholders
RECRO PHARMA INC shareholders Q3 2015
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 2,202,420$6,145,0003.11%
Samjo Capital LLC 560,000$1,562,0001.16%
MAK CAPITAL ONE LLC 1,224,264$3,416,0000.81%
Cowen Prime Services LLC 470,500$1,313,0000.50%
Portolan Capital Management 1,957,283$5,461,0000.43%
Parkman Healthcare Partners LLC 601,967$1,679,0000.39%
Rubric Capital Management LP 1,076,587$3,004,0000.18%
Frontier Wealth Management LLC 49,112$2,142,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 466,992$1,303,0000.16%
AWM Investment Company, Inc. 391,304$1,092,0000.12%
View complete list of RECRO PHARMA INC shareholders